Maureen Japha is the director for regulatory policy at FasterCures and legal counsel for the Milken Institute. Japha is actively involved in FasterCures’ efforts to advance the science of patient input, working with stakeholders to identify and develop tools and resources to more effectively integrate patient perspectives into the processes by which new therapies are discovered, developed, and delivered. As part of these efforts, Japha represented FasterCures at stakeholder meetings for both the Prescription Drug User Fee Act VI and the Medical Device User Fee Amendments IV. She has also been involved in the development of the FasterCures/Avalere Patient-Perspective Value Framework—a multistakeholder effort to develop a value framework that incorporates and reflects the patient’s perspective on value. Japha also leads FasterCures’ university-foundation relations program, where she works to build more effective partnerships between patient foundations and universities, focusing on developing and disseminating best practices. Prior to joining FasterCures, Japha was an associate at Covington & Burling, LLP, where she worked on a range of intellectual property and regulatory issues, with a primary focus on Hatch-Waxman litigation. During her time at Covington, Japha also maintained an active pro bono practice, including a six-month rotation at D.C.’s Children’s Law Center. Japha holds a BS in biology from Tufts University and earned her JD from Washington University School of Law in St. Louis.
Recent Posts by Maureen Japha
Despite the drive toward value-based health care reimbursement and patients’ ever increasing financial stake in their own health care treatment, many traditional value assessment tools fail to consider value from the patient’s perspective.